MANETTI, MIRKO
 Distribuzione geografica
Continente #
NA - Nord America 16.069
EU - Europa 9.463
AS - Asia 8.358
SA - Sud America 1.398
AF - Africa 304
OC - Oceania 174
Continente sconosciuto - Info sul continente non disponibili 7
Totale 35.773
Nazione #
US - Stati Uniti d'America 15.867
RU - Federazione Russa 3.557
SG - Singapore 2.361
CN - Cina 2.091
PL - Polonia 1.686
HK - Hong Kong 1.150
BR - Brasile 1.110
IT - Italia 935
VN - Vietnam 913
IE - Irlanda 859
KR - Corea 761
SE - Svezia 656
FR - Francia 431
FI - Finlandia 383
DE - Germania 320
IN - India 312
GB - Regno Unito 208
AU - Australia 172
JP - Giappone 147
ID - Indonesia 121
CA - Canada 114
JO - Giordania 104
AR - Argentina 101
NL - Olanda 94
UA - Ucraina 80
BD - Bangladesh 72
IQ - Iraq 66
CI - Costa d'Avorio 63
ES - Italia 63
MX - Messico 58
TR - Turchia 58
ZA - Sudafrica 50
EC - Ecuador 47
MA - Marocco 46
CH - Svizzera 40
PH - Filippine 35
CO - Colombia 34
PK - Pakistan 34
NG - Nigeria 33
VE - Venezuela 27
BE - Belgio 24
PY - Paraguay 23
TN - Tunisia 20
AZ - Azerbaigian 18
CL - Cile 18
LT - Lituania 18
EG - Egitto 17
SA - Arabia Saudita 17
UZ - Uzbekistan 17
PE - Perù 16
AT - Austria 15
UY - Uruguay 15
BJ - Benin 13
AE - Emirati Arabi Uniti 12
KE - Kenya 12
UG - Uganda 11
NP - Nepal 10
RO - Romania 10
DK - Danimarca 9
LV - Lettonia 9
MK - Macedonia 9
CZ - Repubblica Ceca 8
JM - Giamaica 8
KZ - Kazakistan 8
SC - Seychelles 8
TH - Thailandia 8
NO - Norvegia 7
SN - Senegal 7
GR - Grecia 6
LU - Lussemburgo 6
BO - Bolivia 5
DZ - Algeria 5
AL - Albania 4
BG - Bulgaria 4
CG - Congo 4
DO - Repubblica Dominicana 4
ET - Etiopia 4
EU - Europa 4
IR - Iran 4
KG - Kirghizistan 4
LB - Libano 4
MD - Moldavia 4
ML - Mali 4
PS - Palestinian Territory 4
RS - Serbia 4
TW - Taiwan 4
BY - Bielorussia 3
CR - Costa Rica 3
IL - Israele 3
LK - Sri Lanka 3
PA - Panama 3
SI - Slovenia 3
SY - Repubblica araba siriana 3
XK - ???statistics.table.value.countryCode.XK??? 3
AO - Angola 2
BB - Barbados 2
BH - Bahrain 2
GA - Gabon 2
GT - Guatemala 2
GY - Guiana 2
Totale 35.740
Città #
Santa Clara 3.110
Ashburn 2.061
Singapore 1.794
Warsaw 1.678
Fairfield 1.508
Hong Kong 955
Dublin 844
Seoul 753
Chandler 732
Woodbridge 685
Seattle 611
Cambridge 605
Houston 574
San Jose 507
Hefei 505
Wilmington 462
Beijing 390
Ho Chi Minh City 289
Florence 240
Los Angeles 227
Ann Arbor 226
Lauterbourg 225
Princeton 222
Hanoi 218
Lawrence 213
Altamura 206
The Dalles 197
Buffalo 172
Helsinki 165
Moscow 157
Mumbai 154
Dallas 152
Melbourne 146
Council Bluffs 144
Medford 138
Munich 136
Tokyo 133
New York 125
Paris 125
Jacksonville 120
Boston 119
Boardman 112
São Paulo 107
San Diego 90
Jakarta 83
Shanghai 78
Kent 73
Abidjan 63
Clifton 61
Redondo Beach 58
Orem 53
Falls Church 51
Chicago 48
Turku 47
London 46
Montreal 45
Chennai 44
Guangzhou 41
Dong Ket 40
Norwalk 40
Rio de Janeiro 39
Milan 38
Lappeenranta 37
Da Nang 36
Frankfurt am Main 36
Phoenix 34
Abuja 33
Johannesburg 33
Toronto 32
Zeist 32
Atlanta 30
Baghdad 29
Hillsboro 29
Haiphong 28
Brooklyn 27
Rome 27
Barcelona 24
Bengaluru 23
Tianjin 23
Yubileyny 23
Andover 22
Casablanca 22
Belo Horizonte 21
Izmir 21
Pune 21
Shenzhen 21
Biên Hòa 20
Bern 19
Denver 19
Fiesole 19
Manchester 19
Porto Alegre 19
Perth 18
West Jordan 18
Baku 17
Brasília 17
Brussels 16
Castelliri 16
Stockholm 16
Tashkent 15
Totale 24.192
Nome #
Systemic Sclerosis Sera Impair Angiogenic Performance of Dermal Microvascular Endothelial Cells: Therapeutic Implications of Cyclophosphamide 351
Angiogenic T cell expansion correlates with severity of peripheral vascular damage in systemic sclerosis 331
Plexin-D1/Semaphorin 3E pathway may contribute to dysregulation of vascular tone control and defective angiogenesis in systemic sclerosis 320
Altered Immunoregulation in Rheumatoid Arthritis: The Role of Regulatory T Cells and Proinflammatory Th17 Cells and Therapeutic Implications 295
The crowded crossroad to angiogenesis in systemic sclerosis: where is the key to the problem? 283
Endothelial-to-mesenchymal transition contributes to endothelial dysfunction and dermal fibrosis in systemic sclerosis 280
Anti-Fas IgM monoclonal antibody (anti-Fas mAb) effect on haemophilic arthropathy (HA) synoviocytes 279
Multimodal imaging in the diagnosis and evaluation of intestinal malrotations in adults: a case report 274
Systemic sclerosis sera affect fibrillin-1 deposition by dermal blood microvascular endothelial cells: therapeutic implications of cyclophosphamide 271
Decreased expression of the endothelial cell-derived factor EGFL7 in systemic sclerosis: potential contribution to impaired angiogenesis and vasculogenesis 257
Clinical, instrumental, serological and histological findings suggest that hemophilia B may be less severe than hemophilia A 253
A genetic variation located in the promoter region of the UPAR (CD87) gene is associated with the vascular complications of systemic sclerosis 249
Longitudinal assessment of the impact of adapted physical activity on upper limb disability and quality of life in breast cancer survivors from an Italian cohort 242
Decreased expression of neuropilin-1 as a novel key factor contributing to peripheral microvasculopathy and defective angiogenesis in systemic sclerosis 241
Psychological well-being and quality of life in visually impaired baseball players: An Italian national survey 240
The "myth" of loss of angiogenesis in systemic sclerosis: A pivotal early pathogenetic process or just a late unavoidable event? 239
A case of in vivo iontophoresis-assisted corneal collagen cross-linking for keratoconus: An immunohistochemical study 238
Agonistic anti-human Fas monoclonal antibody induces fibroblast-like synoviocyte apoptosis in haemophilic arthropathy: potential therapeutic implications 221
Role of a Structured Physical Activity Pathway in Improving Functional Disability, Pain and Quality of Life in a Case of Breast and Gynecological Cancer Survivorship 218
Proangiogenic effects of soluble α-Klotho on systemic sclerosis dermal microvascular endothelial cells 211
Telocytes in normal and keratoconic human cornea: an immunohistochemical and transmission electron microscopy study 211
A loss of telocytes accompanies fibrosis of multiple organs in systemic sclerosis 209
A case of mandible hypoplasia treated with autologous bone graft from mandibular symphysis: Expression of VEGF and receptors in bone regeneration. 209
A two-step immunomagnetic microbead-based method for the isolation of human primary skin telocytes/CD34+ stromal cells 205
Vascular leaking, a pivotal and early pathogenetic event in systemic sclerosis: should the door be closed? 203
Angiotensin II type 2 receptor (AT2R) as a novel modulator of inflammation in rheumatoid arthritis synovium 203
Pathophysiology of Hemophilic Arthropathy 202
Systemic sclerosis-like histopathological features in the myocardium of uPAR-deficient mice 201
Self-reported active lifestyle behavior and upper limb disability in breast cancer survivors following a structured adapted physical activity intervention 199
Severe fibrotic changes and altered expression of angiogenic factors in maternal scleroderma: placental findings. 197
Bone marrow-derived mesenchymal stem cells from early diffuse systemic sclerosis exhibit a paracrine machinery and stimulate angiogenesis in vitro 197
TNF-α/TNF-R System May Represent a Crucial Mediator of Proliferative Synovitis in Hemophilia A 197
Glycolysis-derived acidic microenvironment as a driver of endothelial dysfunction in systemic sclerosis 196
Cardiac Telocyte-Derived Exosomes and Their Possible Implications in Cardiovascular Pathophysiology 191
Long-Term Benefits of Adapted Physical Activity on Upper Limb Performance and Quality of Life in Breast Cancer Survivors 190
Systemic Sclerosis Serum Steers the Differentiation of Adipose-Derived Stem Cells Toward Profibrotic Myofibroblasts: Pathophysiologic Implications 190
Autologous mesenchymal stem cells foster revascularization of ischemic limbs in systemic sclerosis: a case report 188
Visually impaired dancers vs other sound input-based sport athletes: survey on psychological well-being and quality of life 187
Enthesopathy and involvement of synovio-entheseal complex in systemic sclerosis: an ultrasound pilot study 186
Targeting anticoagulant protein S to improve hemostasis in hemophilia 183
The IL1-like cytokine IL33 and its receptor ST2 are abnormally expressed in the affected skin and visceral organs of patients with systemic sclerosis 182
XIII National Congress SISMES - Feasibility and efficacy of an adapted physical activity protocol during COVID-19 pandemic: lower limb functional and strength recovery in a young athlete affected by cutaneous melanoma 181
POS0613 THE ROLE OF MICROBIOTA IN DIFFERENT DISEASE STAGES OF SYSTEMIC SCLEROSIS: A POSSIBLE IMPACT IN GASTROINTESTINAL TRACT DISEASE ACTIVITY? 181
The differential crosstalk of the skin-gut microbiome axis as a new emerging actor in systemic sclerosis 181
Evidence for a Derangement of the Microvascular System in Patients with a Very Early Diagnosis of Systemic Sclerosis 181
Reappraising the microscopic anatomy of human testis: identification of telocyte networks in the peritubular and intertubular stromal space 179
Co-expression of the SARS-CoV-2 entry receptors ACE2 and TMPRSS2 in healthy human conjunctiva 179
Mobilization of lymphatic endothelial precursor cells and lymphatic neovascularization in primary Sjögren's syndrome 177
Slit2/Robo4 axis may contribute to endothelial cell dysfunction and angiogenesis disturbance in systemic sclerosis 177
Adapted Physical Activity Protocol for Lower Limb Functional and Strength Recovery in a Young Athlete with Cutaneous Melanoma: Feasibility and Efficacy during COVID-19 Pandemic 176
Blockade of Sialylation with Decrease in Polysialic Acid Levels Counteracts Transforming Growth Factor β1-Induced Skin Fibroblast-to-Myofibroblast Transition 176
The -670G>A polymorphism in the FAS gene promoter region influences the susceptibility to systemic sclerosis 174
Effects of a specific adapted upper limb exercise on lymphedema in breast cancer survivors: a pilot study 174
Effectiveness of an Adapted Physical Activity Protocol for Upper Extremity Recovery and Quality of Life Improvement in a Case of Seroma after Breast Cancer Treatment 174
Bone Marrow-Mesenchymal Stromal Cell Secretome as Conditioned Medium Relieves Experimental Skeletal Muscle Damage Induced by Ex Vivo Eccentric Contraction 174
Quality of life improvement in breast cancer survivors affected by upper limb lymphedema through a novel multiperspective physical activity methodology: a monocentric pilot study 174
Differential expression of stromal cell-derived factor 1 and its receptor CXCR4 in the skin and endothelial cells of systemic sclerosis patients: Pathogenetic implications 173
Evidence for the prevention of enthesitis in HLA-B27/hβ(2)m transgenic rats treated with a monoclonal antibody against TNF-α. 173
Vascular biomarkers and correlation with peripheral vasculopathy in systemic sclerosis 173
Stiff skin syndrome: evidence for an inflammation-independent fibrosis? 170
Neuropeptides activate TRPV1 in rheumatoid arthritis fibroblast-like synoviocytes and foster IL-6 and IL-8 production. 170
Extracellular Lactic Acidosis of the Tumor Microenvironment Drives Adipocyte-to-Myofibroblast Transition Fueling the Generation of Cancer-Associated Fibroblasts 169
Extracellular lactic acidosis drives reprogramming of human subcutaneous adipocytes toward pathogenic myofibroblasts 169
Telocytes are reduced during fibrotic remodelling of the colonic wall in ulcerative colitis 169
Blocking Protein S Improves Hemostasis in Hemophilia A and B 169
Lymphatic Endothelial-to-Myofibroblast Transition: A Potential New Mechanism Underlying Skin Fibrosis in Systemic Sclerosis 167
Occult spondyloarthritis in inflammatory bowel disease 167
A candidate gene study reveals association between a variant of the SRp55 splicing factor gene and systemic sclerosis 167
Morphological evidence for telocytes as stromal cells supporting satellite cell activation in eccentric contraction-induced skeletal muscle injury 167
Concomitant Spondyloarthritis and Tenosynovial Giant Cell Tumor in Pigmented Villonodular Synovitis Challenging Cases 167
Do new and old biomarkers of early undifferentiated arthritis correlate with Arthritis Impact Measurement Scales? 167
Adapted physical activity protocol for the management of breast cancer-related upper limb lymphedema 166
Tailored sailing experience to reduce psychological distress and improve the quality of life of breast cancer survivors: A survey-based pilot study 166
Adapted Training to Boost Upper Body Sensorimotor Control and Daily Living Functionality in Visually Impaired Baseball Players 165
DECIPHERING THE GUT MICROBIOTA OF VERY EARLY SYSTEMIC SCLEROSIS (VEDOSS) PATIENTS: A TAXONOMIC AND FUNCTIONAL CHARACTERIZATION 165
Disease Activity Improvement in Rheumatoid Arthritis Treated with Tumor Necrosis Factor-α Inhibitors Correlates with Increased Soluble Fas Levels. 165
A loss of telocytes accompanies fibrosis of multiple organs in systemic sclerosis 165
Changes in the telocyte/CD34+ stromal cell and α-SMA+ myoid cell networks in human testicular seminoma 163
Evidence for progressive reduction and loss of telocytes in the dermal cellular network of systemic sclerosis 160
Survey on Psychological Well-Being and Quality of Life in Visually Impaired Individuals: Dancesport vs. Other Sound Input-Based Sports 160
Physical activity and sport practice to improve balance control of visually impaired individuals: a narrative review with future perspectives 159
Circulating Neurovascular Guidance Molecules and Their Relationship with Peripheral Microvascular Impairment in Systemic Sclerosis 159
Characterization and distribution of sialic acids in human testicular seminoma 159
Autoantibodies as putative biomarkers and triggers of cell dysfunctions in systemic sclerosis 158
A loss of telocytes accompanies fibrosis of multiple organs in systemic sclerosis 158
Morphological evidence of telocytes in human synovium 158
Reactive agility and pitching performance improvement in visually impaired competitive Italian baseball players: an innovative training and evaluation proposal 157
Biofeedback-Based Proprioceptive Training to Improve Functional Prerequisites of Dragon Boating in Breast Cancer Survivors 157
Inactivation of urokinase-type plasminogen activator receptor (uPAR) gene induces dermal and pulmonary fibrosis and peripheral microvasculopathy in mice: a new model of experimental scleroderma? 157
Adipose-derived stem cells: Pathophysiologic implications vs therapeutic potential in systemic sclerosis 157
Lymphatic endothelial progenitor cells and vascular endothelial growth factor-C in spondyloarthritis and Crohn’s disease: two overlapping diseases? 156
Insulin-like growth factor binding protein 6 in rheumatoid arthritis: A possible novel chemotactic factor? 156
Decreased Serum Levels of SIRT1 and SIRT3 Correlate with Severity of Skin and Lung Fibrosis and Peripheral Microvasculopathy in Systemic Sclerosis 156
THE CROSSTALK OF THE SKIN-ORAL-GUT MICROBIOME AXIS IN LIMITED AND DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS 156
Systemic Sclerosis Serum Significantly Impairs the Multi-Step Lymphangiogenic Process: in Vitro Evidence 155
The Soluble Guanylate Cyclase Stimulator BAY 41-2272 Attenuates Transforming Growth Factor β1-Induced Myofibroblast Differentiation of Human Corneal Keratocytes 154
Telocytes in minor salivary glands of primary Sjogren’s syndrome: association with the extent of inflammation and ectopic lymphoid neogenesis 154
Differential expression of junctional adhesion molecules in different stages of systemic sclerosis 154
STIMULATION OF SOLUBLE GUANYLATE CYCLASE (sGC) FOSTERS ANGIOGENESIS AND BLUNTS ENDOTHELIAL-TO-MESENCHYMAL TRANSITION (EndoMT) OF SYSTEMIC SCLEROSIS (SSc) DERMAL MICROVASCULAR ENDOTHELIAL CELLS 154
Immunohistochemical and ultrastructural identification of telocytes in the lamina propria of human vaginal mucosa 153
Totale 19.216
Categoria #
all - tutte 99.646
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 99.646


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021293 0 0 0 0 0 0 0 0 0 0 152 141
2021/20221.363 30 84 72 71 57 112 51 64 101 83 144 494
2022/20233.474 374 641 149 245 231 637 489 187 325 48 84 64
2023/20241.460 43 174 281 72 104 198 84 233 22 78 98 73
2024/202510.189 380 1.072 701 1.486 2.962 1.051 334 587 462 321 369 464
2025/202611.885 1.301 1.676 1.374 1.467 1.418 509 1.536 719 978 788 119 0
Totale 36.380